Health Care & Life Sciences » Pharmaceuticals | Chongqing Taiji Industry

Chongqing Taiji Industry | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6,557
6,905
7,112
7,866
8,620
10,555
Cost of Goods Sold (COGS) incl. D&A
4,846
5,057
5,136
5,737
5,732
6,552
Gross Income
1,711
1,848
1,976
2,129
2,888
4,004
SG&A Expense
1,513
1,720
2,112
2,436
2,524
3,530
EBIT
162
90
-
-
356
458
Unusual Expense
-
-
249
182
-
213
Non Operating Income/Expense
139
6
584
1,228
43
144
Interest Expense
340
379
324
254
254
298
Pretax Income
64
253
365
878
191
154
Income Tax
20
10
139
26
86
78
Equity in Affiliates
-
-
4
-
9
14
Consolidated Net Income
44
264
230
852
95
62
Net Income
13
277
232
856
98
70
Net Income After Extraordinaries
13
277
232
856
98
70
Net Income Available to Common
13
277
232
856
98
70
EPS (Basic)
0.03
0.65
0.54
2.01
0.23
0.13
Basic Shares Outstanding
427
427
427
427
427
546
EPS (Diluted)
0.03
0.65
0.54
2.01
0.23
0.13
Diluted Shares Outstanding
427
427
427
427
427
546
EBITDA
316
254
2
120
549
670
Other Operating Expense
35
38
31
13
8
16
Non-Operating Interest Income
35
37
36
42
47
61
Minority Interest Expense
31
13
1
4
3
8

About Chongqing Taiji Industry

View Profile
Address
38 Huanglong Road
Chongqing Chongqing 401147
China
Employees -
Website http://www.taiji.com
Updated 07/08/2019
Chongqing Taiji Industry (Group) Co., Ltd. engages in the processing, production and distribution of Chinese patent medicines and health care products. It offers capsules, syrup, oral liquid, lyophilized series, tablets, infusion series and injections. The company was founded on November 18, 1993 and is headquartered in Chongqing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.